William Pickering
Stock Analyst at Bernstein
(2.10)
# 3,000
Out of 5,241 analysts
44
Total ratings
44%
Success rate
-2.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics | Maintains: Market Perform | $13 → $17 | $13.67 | +24.36% | 3 | May 13, 2026 | |
| DYN Dyne Therapeutics | Maintains: Market Perform | $23 → $24 | $17.29 | +38.81% | 1 | May 13, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintains: Market Perform | $50 → $56 | $48.41 | +15.68% | 2 | May 13, 2026 | |
| BEAM Beam Therapeutics | Maintains: Outperform | $40 → $39 | $27.93 | +39.63% | 3 | May 13, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $35 → $46 | $76.67 | -40.00% | 3 | May 13, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $94 → $82 | $51.81 | +58.27% | 7 | May 5, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintains: Outperform | $577 → $572 | $436.95 | +30.91% | 7 | May 5, 2026 | |
| ALLO Allogene Therapeutics | Maintains: Market Perform | $1.6 → $3.85 | $2.00 | +92.50% | 3 | Apr 14, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $925 → $921 | $698.25 | +31.90% | 4 | Apr 8, 2026 | |
| BBIO BridgeBio Pharma | Initiates: Outperform | $94 | $66.13 | +42.14% | 1 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $34 → $9 | $8.76 | +2.74% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $155 → $157 | $192.95 | -18.63% | 1 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $52 → $72 | $13.23 | +444.22% | 1 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $13 | $17.55 | -25.93% | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $314 → $310 | $286.98 | +8.02% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $74.23 | - | 2 | Jun 14, 2024 |
Intellia Therapeutics
May 13, 2026
Maintains: Market Perform
Price Target: $13 → $17
Current: $13.67
Upside: +24.36%
Dyne Therapeutics
May 13, 2026
Maintains: Market Perform
Price Target: $23 → $24
Current: $17.29
Upside: +38.81%
CRISPR Therapeutics AG
May 13, 2026
Maintains: Market Perform
Price Target: $50 → $56
Current: $48.41
Upside: +15.68%
Beam Therapeutics
May 13, 2026
Maintains: Outperform
Price Target: $40 → $39
Current: $27.93
Upside: +39.63%
Arrowhead Pharmaceuticals
May 13, 2026
Maintains: Market Perform
Price Target: $35 → $46
Current: $76.67
Upside: -40.00%
BioMarin Pharmaceutical
May 5, 2026
Maintains: Outperform
Price Target: $94 → $82
Current: $51.81
Upside: +58.27%
Vertex Pharmaceuticals
May 5, 2026
Maintains: Outperform
Price Target: $577 → $572
Current: $436.95
Upside: +30.91%
Allogene Therapeutics
Apr 14, 2026
Maintains: Market Perform
Price Target: $1.6 → $3.85
Current: $2.00
Upside: +92.50%
Regeneron Pharmaceuticals
Apr 8, 2026
Maintains: Outperform
Price Target: $925 → $921
Current: $698.25
Upside: +31.90%
BridgeBio Pharma
Dec 11, 2025
Initiates: Outperform
Price Target: $94
Current: $66.13
Upside: +42.14%
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $8.76
Upside: +2.74%
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $192.95
Upside: -18.63%
Oct 27, 2025
Downgrades: Market Perform
Price Target: $52 → $72
Current: $13.23
Upside: +444.22%
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $17.55
Upside: -25.93%
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $286.98
Upside: +8.02%
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $74.23
Upside: -